<html><head></head><body><h1>Phosenamine</h1><p class="drug-subtitle"><b>Generic Name:</b> hyoscyamine sulfate, methenamine, phenyl salicylate, sodium phosphate, monobasic, monohydrate and methylene blue<br/>
<b>Dosage Form:</b> capsule<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Side Effects</li>
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Indications and Usage</li>
<li>Dosage and Administration</li>
<li>Contraindications</li>
<li>Warnings and Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Drug Interactions</li>
<li class="ddc-toggle-hidden">Drug Abuse and Dependence</li>
<li class="ddc-toggle-hidden">Overdosage</li>
<li class="ddc-toggle-hidden">Clinical Pharmacology</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><h2>Phosenamine Description</h2><p class="First">Each capsule for oral administration contains:<br/>
Hyoscyamine Sulfate .12 mg<br/>
Methenamine 120 mg<br/>
Phenyl Salicylate 36 mg<br/>
Sodium Phosphate Monobasic 40.8 mg<br/>
Methylene Blue 10 mg<br/>
<br/>
Inactive Ingredients: Dicalcium Phosphate, FD&amp;C Blue #1, FD&amp;C Red #3, Gelatin, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid, Titanium Dioxide, Shellac, Propylene Glycol, Sodium Hydroxide, Povidone.<br/>
<br/></p><h2>Indications and Usage for Phosenamine</h2><p class="First">Phosenamine is indicated for the relief of discomfort of the urinary tract resulting from irritative voiding, diagnostic procedures, hypermotility, inflammation, and/or certain types of lower urinary tract infections.</p><h2>Phosenamine Dosage and Administration</h2><h2>Contraindications</h2><p class="First">Phosenamine is contraindicated in patients hypersensitive to any of its ingredients. Risk benefits should be carefully considered when the following medical problems exist: achalasia of esophagus, atony of colon, diseases of cardiovascular system, gastrointestinal hemorrhage; claucoma; hemolytic anemia from pyruvate kinase and G6PD deficiencies, infected urolithiasis, myasthenia gravis, paralytic ileus, severe ulcerative colitis, toxic megacolon; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).</p><h2>Warnings and Precautions</h2><p class="First">Do not exceed recommended dosage. This drug may make you dizzy or drowsy or cause blurred vision; use caution while driving, using machinery, or doing any activity that requires alertness or clear vision. Limit alcohol consumption. Cross sensitivity and/or related problems: Patients intolerant of other belladonna alkaloids or other salicylates may be intolerant of this medication also. Delay in gastric emptying could complicate the management of gastric ulcers. There have been no studies to establish the safety or prolonged use of this product in humans. No known long-term animal studies have been performed to evaluate carcinogenic potential.<br/>
<br/>
Pregnancy: Teratogenic Effects. Pregnancy Category C: Hyoscyamine Sulfate and Methenamine cross the placenta. Studies have not been done in animals or humans. It is not known whether Phosenamine capsules cause fetal harm when administered to a pregnant woman or can affect reproduction. Phosenamine capsules should be given to a pregnant woman only if clearly needed.<br/>
<br/>
Nursing Mothers: Problems in humans have not been documented; however, Methenamine and traces of Hyoscyamine Sulfate are excreted in breast milk.<br/>
Phosenamine capsules should be given to a lactating woman only if clearly needed.<br/>
Discuss the risks and benefits with your doctor.<br/>
<br/>
Pediatric Use: Infants and young children are especially susceptible to the toxic effect of the belladonna alkaloids (Hyoscyamine Sulfate). This product contains salicylate, which is related to aspirin. Children and teenagers should not take aspirin, aspirin-containing or aspirin-related medications if they have chickenpox, influenza, or any undiagnosed illness without first consulting a doctor. A rare but serious illness known as Reye’s syndrome may occur. This medication is not recommended for children younger than 6 years.<br/>
<br/>
Geriatric Use: Use with caution in elderly patients as they may respond to usual doses of Hyoscyamine Sulfate excitement, agitation, drowsiness or confusion.<br/>
<br/></p><h2>Adverse Reactions</h2><h2>Drug Interactions</h2><h2>Drug Abuse and Dependence</h2><p class="First">A dependence on the use of Phosenamine has not been reported nor expected based on the pharmacology of the ingredients contained in Phosenamine.</p><h2>Overdosage</h2><p class="First">By exceeding the recommended dosage of Phosenamine, symptoms related to the overdose most probably be manifested in the symptoms related to overdose of its individual active ingredients may be expected as follows:<br/></p><p>Hyoscyamine Sulfate: Symptoms associated with overdosage of Phosenamine will most probably be manifested in the symptoms related to overdosage of alkaloid Hyoscyamine Sulfate. Such symptoms as dryness of mucous membranes; dilation of pupils, hot, dry, flushed skin; hyperpyrexia, tachycardia, palpitations; elevated blood pressure, coma; circulatory collapse and death from respiratory failure can occur due to overdosage of these alkaloids.<br/></p><p>Methenamine: If large amounts of the drug (2-8g daily) are used over extended periods (3-4 weeks), bladder and gastrointestinal irritation, painful and frequent urination, albuminuria and gross hematuria may be expected.<br/></p><p>Phenyl Slicylate: Symptoms of Phenyl Salicylate overdosage include burning pain in throat and mouth, white necrotic lesions in the mouth, abdominal pain, vomiting, bloody diarrhea, pallor, sweating, weakness, headache, dizziness and tinnitus. The symptoms, however, are not expected to be discernible from those associated with the other active ingredients in Phosenamine.<br/></p><p>Sodium Phosphate Monobasic: Symptoms of Sodium Biphosphate overdosage may include diarrhea, dehydration, and electrolyte imbalances.<br/></p><p>Methylene Blue: Symptoms of Methylene Blue overdosage associated with the overdosage of Phosenamine are not expected to be discernible from those associated with other active ingredients in Phosenamine.<br/>
<br/>
Treatment: Emesis or gastric lavage. Slow intravenous administration of physostigmine in doses of 1 to 4 mg (0.5 to 1 mg in children), repeated as needed in one to two hours to reverse severe antimuscarinic symptoms.<br/>
Administration of small doses of diazepam or baclofen to control excitement and seizures. Artificial respiration with oxygen if needed for respiratory depression. Adequate re-hydration is required. Symptomatic treatment as determined by a doctor.<br/>
<br/>
If overdose is suspected, contact your local poison center or emergency room immediately. US residents can contact the US National Poison Hotline at 1-800-222-1222.<br/>
<br/></p><h2>Phosenamine - Clinical Pharmacology</h2><h2>How is Phosenamine Supplied</h2><p class="First">Phosenamine is available as a purple capsule imprinted “RE 293” bottles of 100 capsules, NDC 68032-293-10. Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure. Store at controlled room temperature 15-30C (59-86F). Keep in a cool, dry place.<br/>
WARNING: Keep this and all drugs out of reach of children.<br/>
Caution: Rx Only<br/>
<br/></p><h2>PACKAGING</h2><p class="First">Sample packaging:</p><p></p><h2>More about Phosenamine (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Drug class: urinary antispasmodics</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Infection</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>